The Menarini Group received the coveted XV Transatlantic Award from the American Chamber of Commerce in Italy for the acquisition of the American biopharmaceutical company, Stemline Therapeutics.

Elcin Barker Ergun, CEO and Board Member of Menarini commented: 'The acquisition of Stemline Therapeutics represents a significant milestone for our company, allowing us to enter the largest pharmaceutical market in the world in which we have aspired to be leaders for some time.

Motivation for the award: For the $ 677 million acquisition of Stemline Therapeutics Inc., an American biopharmaceutical company based in New York. This acquisition allows the Group to enter the US pharmaceutical market and marks for Menarini its first entry into the market for the sale and distribution of oncological therapies.

Contact:

Tel: (055) 56.80.1

Fax: (055) 58.27.71

(C) 2020 Electronic News Publishing, source ENP Newswire